[{"address1": "142 Sansome Street", "address2": "Second Floor", "city": "San Francisco", "state": "CA", "zip": "94104", "country": "United States", "phone": "415 432 9270", "website": "https://www.89bio.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis; and for the treatment of severe hypertriglyceridemia. The company was incorporated in 2018 and is headquartered in San Francisco, California.", "fullTimeEmployees": 70, "companyOfficers": [{"maxAge": 1, "name": "Mr. Rohan  Palekar", "age": 57, "title": "CEO & Director", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 1063871, "exercisedValue": 0, "unexercisedValue": 2824567}, {"maxAge": 1, "name": "Mr. Quoc  Le-Nguyen", "age": 55, "title": "Chief Technical Officer", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 702871, "exercisedValue": 0, "unexercisedValue": 265549}, {"maxAge": 1, "name": "Dr. Harry  Mansbach M.D.", "age": 58, "title": "Chief Medical Officer", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 732871, "exercisedValue": 0, "unexercisedValue": 1428149}, {"maxAge": 1, "name": "Mr. Ryan Stephen Martins", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Francis W. Sarena", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shiva K. Natarajan CPA", "age": 57, "title": "Senior Vice President of Finance & Principal Accounting Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Annie J. Chang M.B.A.", "title": "VP of Investor Relations & Corporate Communications", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amanda  Kurihara", "title": "Vice President of People & Culture", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melissa  Abel", "title": "Senior Vice President of Commercial Strategy", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul  Shin", "title": "Senior Vice President of R&D Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 8, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.8, "open": 8.83, "dayLow": 8.36, "dayHigh": 8.87, "regularMarketPreviousClose": 8.8, "regularMarketOpen": 8.83, "regularMarketDayLow": 8.36, "regularMarketDayHigh": 8.87, "beta": 0.999, "forwardPE": -3.3529413, "volume": 426675, "regularMarketVolume": 426675, "averageVolume": 869824, "averageVolume10days": 413160, "averageDailyVolume10Day": 413160, "bid": 8.53, "ask": 8.58, "bidSize": 100, "askSize": 200, "marketCap": 905530496, "fiftyTwoWeekLow": 6.575, "fiftyTwoWeekHigh": 18.06, "fiftyDayAverage": 8.4861, "twoHundredDayAverage": 9.577825, "currency": "USD", "enterpriseValue": 427970912, "floatShares": 67907368, "sharesOutstanding": 105910000, "sharesShort": 6838127, "sharesShortPriorMonth": 6155714, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0646, "heldPercentInsiders": 0.0067299996, "heldPercentInstitutions": 1.0206, "shortRatio": 9.43, "shortPercentOfFloat": 0.083000004, "bookValue": 4.908, "priceToBook": 1.7420539, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -174612000, "trailingEps": -1.96, "forwardEps": -2.55, "pegRatio": -0.36, "enterpriseToEbitda": -2.238, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "ETNB", "underlyingSymbol": "ETNB", "shortName": "89bio, Inc.", "longName": "89bio, Inc.", "firstTradeDateEpochUtc": 1573482600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "6271fd18-e443-39f3-b14c-3361d6248f55", "gmtOffSetMilliseconds": -14400000, "currentPrice": 8.55, "targetHighPrice": 53.0, "targetLowPrice": 12.0, "targetMeanPrice": 31.33, "targetMedianPrice": 30.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 9, "totalCash": 531384000, "totalCashPerShare": 5.017, "ebitda": -191216992, "totalDebt": 27347000, "quickRatio": 13.223, "currentRatio": 13.921, "debtToEquity": 5.311, "returnOnAssets": -0.22247, "returnOnEquity": -0.36495, "freeCashflow": -126628248, "operatingCashflow": -165538000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]